BIOR 外汇新闻

Biotech company Biora Therapeutics, Inc. (BIOR) announced Tuesday that its BioJet Systemic Oral Delivery Platform has met key performance milestones as part of its research collaboration with British drug major AstraZeneca plc (AZN.L, AZN).